Align Technology, Inc. (ALGN)
Elliott builds stake in Invisalign maker Align Technology, Bloomberg News reports
Elliott Investment Management has built a significant stake in Align Technology Inc , the maker of Invisalign teeth-straightening products, Bloomberg News reported on Wednesday, citing people familiar with the matter.
Align Technology (ALGN) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Align Technology, Inc. (ALGN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Align Technology, Inc. (ALGN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Are Medical Stocks Lagging Align Technology (ALGN) This Year?
Here is how Align Technology (ALGN) and Biofrontera Inc. (BFRI) have performed compared to their sector so far this year.
Align Technology, Inc. (ALGN) Presents at Leerink Global Healthcare Conference 2026 Transcript
Align Technology, Inc. (ALGN) Presents at Leerink Global Healthcare Conference 2026 Transcript
Align Technology (ALGN) Down 0% Since Last Earnings Report: Can It Rebound?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
ALGN vs. WST: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?
Here's Why Align Technology (ALGN) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Align Technology (ALGN) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Here is how Align Technology (ALGN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Align Technology: Broad-Based Q4 Outperformance Supports Upside
Align Technology delivered a second consecutive strong quarter, with Q4 results significantly exceeding both market and management expectations. ALGN remains undervalued, trading at a discount to sector and historical multiples, supporting a Buy rating and a raised target price of $195 (11% upside). Clear Aligner segment achieved record volumes, while Systems & Services growth and cost discipline drove margin expansion and robust profitability.
Here's Why Align Technology (ALGN) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
